The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The US Patent and Trademark Office (USPTO) has granted a patent to Vistagen’s non-opioid oral product candidate, AV-101 for ...

The Phase IIa results continue a surge of momentum in a treatment space that last week saw the approval of Vertex’s Journavx ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

FDA approves new type of non-opioid pain medication in two decades - The new drug will be many times more expensive than a ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

"This medication — which is a drug that inhibits ... In addition to acute pain, suzetrigine may also be a solution for neuropathic (nerve) pain, depending on the results of further studies ...

Gabapentinoids are increasingly prescribed as an alternative to pain medicines for nursing home residents, but the reasoning behind the prescriptions — and beliefs about efficacy and deprescribing — ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around four in every 10 patients treated with these drugs, suggests a pooled data analysis of ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.